Paras Healthcare IPO 2026: GMP Today, Price Band, Subscription, Hospital Business and Financial Details

Paras Healthcare IPO 2026: Latest News

Paras Healthcare Limited is launching its mainboard IPO on October 21, 2026, attracting attention from investors interested in India's growing hospital and healthcare industry. The company operates hospitals under the Paras Health brand and specialises in advanced medical treatments across several clinical disciplines.

The IPO aims to raise ₹1,450 crore at a price band of ₹660 to ₹693 per share. The issue combines a fresh issue of ₹500 crore with an offer for sale of ₹950 crore by existing shareholders. The public subscription window will close on October 23, 2026.

The company has also raised approximately ₹652.5 crore from anchor investors at ₹693 per share ahead of the public issue, according to exchange disclosures reported on October 20.

Paras Healthcare IPO Details

Paras Healthcare IPO GMP Today

The grey market premium for Paras Healthcare IPO has been fluctuating in the days leading up to its opening. Reports available before October 20 showed estimates ranging from approximately ₹85 to ₹115 per share.

At the upper price band of ₹693, these figures imply an unofficial estimated price range of ₹778 to ₹808 per share.

These figures are unofficial and reflect different market observations rather than a single confirmed market price. GMP can change rapidly before listing and does not guarantee actual listing gains.

Paras Healthcare IPO Subscription Status

The public issue opens on October 21, 2026. Therefore, live subscription figures for retail investors, non-institutional investors and qualified institutional buyers are not yet available as of October 20.

The anchor investor round was completed on October 19, with approximately ₹652.5 crore raised from 39 funds. The reported participants included several major domestic mutual funds and international institutional investors.

After the IPO opens, investors can monitor category-wise demand to assess how the issue is being received by different investor groups.

About Paras Healthcare Limited

Paras Healthcare is a hospital operator providing tertiary and quaternary medical care through its Paras Health hospital network. The company focuses on specialised treatment and complex medical procedures, serving patients across major cities as well as developing healthcare markets in North India and eastern India.

As of June 30, 2026, its network comprised eight hospitals with an aggregate capacity of 2,211 beds. Its hospitals are located in Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar.

The company's model combines specialist doctors, diagnostic services, advanced medical equipment, inpatient facilities and critical-care services. Its focus on specialised treatments distinguishes it from healthcare providers that concentrate primarily on general medical services.

Paras Healthcare Hospital Network

The company's hospitals serve patients across Haryana, Bihar, Uttar Pradesh, Rajasthan, Jharkhand and Jammu and Kashmir. This regional presence enables it to serve patients who may otherwise need to travel to larger metropolitan healthcare centres for specialised treatment.

Paras Health focuses on expanding access to advanced medical services while developing its hospital infrastructure and specialist treatment capabilities.

Hospital operations require substantial investment in buildings, medical equipment, doctors, nursing teams, technology and patient-care systems. Occupancy levels and the effective utilisation of these resources are therefore important factors in the company's profitability.

Paras Healthcare Medical Specialities

Paras Healthcare focuses on several specialised medical disciplines, including:

• Cardiac sciences: Diagnosis and treatment of heart-related conditions.

• Oncology sciences: Cancer diagnosis, treatment and related care.

• Neurosciences: Treatment of disorders affecting the brain, spine and nervous system.

• Gastro sciences: Medical and surgical care for digestive-system conditions.

• Orthopaedics and sports injury: Bone, joint and musculoskeletal treatment.

• Renal sciences: Medical care for kidney-related conditions.

These specialities can require advanced diagnostic equipment, experienced medical professionals and multidisciplinary treatment teams. The company's ability to attract patients and retain skilled clinicians is an important part of its business model.

Paras Healthcare IPO Financial Performance

Investors should examine Paras Healthcare's revenue growth, profitability, debt position and hospital occupancy before evaluating the IPO.

The company operates a capital-intensive business. Hospitals require ongoing expenditure on medical equipment, infrastructure upgrades, staffing and maintenance, while expansion can create additional financing requirements.

According to the IPO disclosures, the company reported a bed occupancy rate of 61.75% in FY2026, compared with 50.78% in FY2025 and 52.46% in FY2024. This improvement indicates better utilisation of available beds in FY2026, although future performance will depend on patient volumes, capacity additions and operating efficiency.

As of August 31, 2026, the company and its subsidiaries had aggregate secured borrowings of approximately ₹990.33 crore. This debt position makes cash generation and financing costs important considerations for investors.

For an accurate financial comparison, investors should refer to the company's final prospectus for audited revenue, EBITDA, profit after tax, earnings per share and balance-sheet figures.

Paras Healthcare IPO Objectives

The IPO includes a fresh issue of ₹500 crore, while ₹950 crore will be raised through the sale of existing shares.

The fresh issue proceeds are intended primarily for repayment or prepayment of certain outstanding borrowings of the company and its subsidiaries, with the remaining amount allocated to general corporate purposes, subject to the final offer documents.

Debt repayment may help reduce financing obligations and improve financial flexibility. However, the offer-for-sale component represents proceeds received by selling shareholders rather than money directly raised by the company.

This distinction is important when evaluating how much new capital will be available to support the hospital network.

Paras Healthcare Growth Opportunities

India's healthcare industry continues to face demand for specialised treatment, advanced diagnostics and hospital infrastructure. Rising awareness of medical services and the need for complex procedures create opportunities for organised hospital operators.

Paras Healthcare's presence across several states allows it to serve regional markets beyond the largest metropolitan cities. Its specialised treatment portfolio may also support patient referrals for complex procedures.

Nevertheless, hospital expansion requires substantial capital and depends on the availability of skilled doctors, regulatory approvals, patient affordability and efficient management of operating costs.

Paras Healthcare IPO Risks

Investors should consider the following factors before applying:

• High debt levels: Borrowings can increase interest costs and place pressure on cash flows.

• Hospital occupancy: Lower occupancy can reduce revenue while fixed operating costs remain high.

• Capital expenditure: Medical equipment, hospital maintenance and new facilities require continued investment.

• Competition: Hospitals compete for doctors, patients, insurance partnerships and medical specialists.

• Regulatory requirements: Healthcare operations are subject to clinical, licensing and compliance obligations.

• Execution risk: Expansion plans must be managed without compromising patient care or financial performance.

These factors should be assessed alongside the IPO valuation and the company's future expansion plans.

Paras Healthcare IPO Important Dates

The dates are based on the published IPO schedule and should be checked against official exchange updates.

Paras Healthcare IPO: Key Points for Investors

Paras Healthcare is entering the stock market with an issue size of ₹1,450 crore, combining fresh capital with an offer for sale. Its hospital network, specialised treatment capabilities and improved bed occupancy in FY2026 are important aspects of the company's business profile.

At the same time, its borrowing levels, capital requirements and dependence on efficient hospital utilisation deserve attention. The IPO's valuation should be assessed against audited financial results and comparable listed hospital operators.

The latest GMP and subscription figures may provide additional market context, but neither can guarantee a positive listing or long-term investment returns.

Paras Healthcare IPO Summary

Paras Healthcare IPO opens on October 21 and closes on October 23, 2026, at a price band of ₹660–₹693 per share. The company aims to raise ₹1,450 crore through a ₹500 crore fresh issue and a ₹950 crore offer for sale.

Operating eight hospitals with a combined capacity of 2,211 beds as of June 30, 2026, Paras Healthcare focuses on specialised medical services across several regions of India.

The issue is expected to list on October 28, 2026. Investors should review the final prospectus, debt position, audited financial performance and valuation before making an application decision.